Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
46
Participants
Timeline
Start Date
March 31, 2003
Conditions
Colorectal Cancer (CRC)
Interventions
DRUG
E7070
Trial Locations (4)
F-69373
Centre Léon Bérard, Lyon
F-75005
Institut Curie, Paris
D-45122
Universitätsklinikum der GHS-Essen, Essen
1066 CX
Netherlands Cancer Institute, Amsterdam
All Listed Sponsors
lead
Eisai Limited
INDUSTRY
NCT00165854 - Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter